The intermittent pneumatic compression ipc devices market has seen considerable growth due to a variety of factors.
• The market size for intermittent pneumatic compression (IPC) devices has seen a robust growth over recent years and is projected to rise from $1.44 billion in 2024 to $1.58 billion in 2025, marking a compound annual growth rate (CAGR) of 9.9%.
The expansion during the previous periods can be ascribed to a better understanding of diseases, improved awareness and diagnostics, evolving healthcare policies, partnership in clinical studies, proactive patient advocacy, and educational initiatives for doctors.
The intermittent pneumatic compression ipc devices market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations indicate a solid expansion in the market size of intermittent pneumatic compression (IPC) devices in the coming years. The market is predicted to reach $2.16 billion by 2029, displaying a compound annual growth rate (CAGR) of 8.1%.
This anticipated growth within the forecasted timeframe could be credited to factors such as the escalating number of patients, an enhanced emphasis on patient quality of life, an increase in research collaborations, various worldwide health initiatives, and improved healthcare accessibility. Some of the predicted key trends within this forecasted timeframe are the advent of targeted therapies, the creation of oral and injectable medications, the exploration of immune modulation strategies, the launch of disease-altering agents, and a concentration on personalized medicine strategies.
The intermittent pneumatic compression (IPC) devices market is anticipated to grow due to the rising number of spinal cord injury patients. Spinal cord injuries can lead to varying degrees of paralysis and sensory impairment, inducing functional losses. IPC devices are commonly incorporated in the management of spinal cord injuries as a preventative measure against deep vein thrombosis (DVT) by actively promoting blood circulation via the sequential compression of the lower extremities. Around 18,000 new cases of spinal cord injuries are reported yearly as per the National Spinal Cord Injury Statistical Center, a government entity in the US. In 2023, the yearly spinal cord injuries occurrence rate sat around 54 cases for every 1 million individuals. This surge in spinal cord injury cases propels the growth of the intermittent pneumatic compression (IPC) devices market. The growth of the intermittent pneumatic compression (IPC) devices market is also expected to be fueled by the increasing accident rates. Accidents, being unforeseeable events leading to harm or damage due to unintentional causes, often result in fractures and soft-tissue injuries. In these situations, IPC devices are utilized for treatment. As per the data from the European Commission, deaths from road accidents in EU rose by 4%, tallying 20,640 deaths last year, showing an increase from 2021. Consequently, such rise in accident rates is driving the expansion of the intermittent pneumatic compression (IPC) devices market.
The intermittent pneumatic compression (IPC) devices market covered in this report is segmented –
1) By Type: Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE)
2) By Distribution Channel: Clinics, Pharmacies, Online Channels, Other Offline Channels
3) By Application: Home Use, Hospital
Subsegments:
1) By Deep Vein Thrombosis (DVT): Portable DVT Compression Devices, Non-Portable (Stationary) DVT Compression Devices, Sequential Compression Devices for DVT
2) By Pulmonary Embolism (PE): Portable PE Compression Devices, Non-Portable (Stationary) PE Compression Devices, Sequential Compression Devices for PE
Leading corporations in the intermittent pneumatic compression (IPC) devices market are placing a stronger emphasis on innovating wearables with an aim to create a distinct competitive advantage. These wearable IPC devices not only enhance circulation but also prevent conditions like deep vein thrombosis mainly during prolonged periods of inactivity. To exemplify, Fist Assist Devices LLC, an American medical device firm, in March 2022, unveiled the Fist Assist Model FA-1, the first globally recognized wearable device for presurgical vein dilation, which helps promote arteriovenous fistula (AVF). This wearable IPC device, which is worn on the arm, has an automatic operation eliminating the requirement for manual tuning, thereby diminishing potential user errors. It assists in vein dilation through cyclic pressure application to the arm, leading to enhanced blood flow and vein dilation.
Major companies operating in the intermittent pneumatic compression (ipc) devices market report are:
• Cardinal Health Inc.
• 3M Company
• Medtronic PLC
• Stryker Corporation
• Tyco International PLC
• Medline Industries LP
• B. Braun Melsungen AG
• Zimmer Biomet Holdings Inc.
• Smith & Nephew PLC
• Getinge AB
• Enovis Corporation
• Arjo AB
• Tactile Systems Technology Inc.
• ThermoTek Inc.
• Encompass Group LLC
• Hyperice Inc.
• Breg Inc.
• Currie Medical Specialties Inc.
• ManaMed Inc.
• Bio Compression Systems Inc.
• Direct Healthcare Group Ltd.
• Devon Medical Inc.
• Mego Afek A.C. Ltd.
• BSN medical GmbH
• Compression Therapy UK Limited
• Air Relax Inc.
• Innova Medical Group Inc.
North America was the largest region in the intermittent pneumatic compression (IPC) devices market in 2024. The regions covered in the intermittent pneumatic compression (ipc) devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.